Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lasaitiene, D.
Right arrow Articles by Friberg, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lasaitiene, D.
Right arrow Articles by Friberg, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 2534-2541
© 2003 European Renal Association-European Dialysis and Transplant Association


Original Article

Perturbed medullary tubulogenesis in neonatal rat exposed to renin–angiotensin system inhibition

Daina Lasaitiene1, Yun Chen1, Gregor Guron1, Niels Marcussen4, Andrzej Tarkowski3, Esbjorn Telemo3 and Peter Friberg1,2

1Department of Physiology, Institute of Physiology and Pharmacology, 2Department of Clinical Physiology, 3Department of Rheumatology and Inflammation Research, University of Gothenburg, Sweden and 4Department of Pathology, University of Aarhus, Denmark

Correspondence and offprint requests to: Daina Lasaitiene, MD, Department of Physiology, Institute of Physiology and Pharmacology, University of Gothenburg, Box 432, S-405 30, Gothenburg, Sweden. Email: daina.lasaitiene{at}fysiologi.gu.se

Background. Pharmacological interruption of the angiotensin II type-1 receptor (AT1) signalling during nephrogenesis in rats induces irreversible abnormalities in kidney morphology, comprising papillary atrophy and tubulointerstitial damage, which are characterized by tubular dilatation/atrophy and interstitial inflammation/fibrosis. This study determined the time course for development of tubular structural and inflammatory changes and possible cytokine production in the renal medulla of newborn rats exposed to angiotensin-converting enzyme (ACE) inhibition. Additionally, medullary expression of E-cadherin, a marker for tubular formation, was investigated in ACE-inhibited rats.

Methods. Newborn rats were exposed (postnatal days 0–12) to ACE inhibitor enalapril and killed at days 1, 2, 4, 9 and 13. One kidney was used for morphological evaluation and the other for immunohistochemistry, using antibodies directed against monocytes/macrophages, T cells and E-cadherin on frozen sections. In a separate experiment, rats were treated for 9 days and had their kidneys processed for western immunoblot and immunohistochemistry, where antibodies directed against monocyte chemoattractant protein-1 (MCP-1) and tumour necrosis factor-{alpha} (TNF-{alpha}) were used on paraffin sections.

Results. In renal medulla from enalapril-treated rats, volume fractions of tubular lumens and interstitium were increased from postnatal days 2 and 4, respectively, while that of tubular cells was decreased from 4 days of age. Concomitant loss and/or reduction in E-cadherin expression (from day 2) was observed in dilated medullary tubules of enalapril-treated rats. Furthermore, in the medulla of enalapril-treated rats, the increased number of ED2+ (resident macrophages) cells, followed by the increase in ED1+ (monocytes/macrophages) and CD4+ T cells, was observed at days 9 and 13, respectively. This was accompanied by increased medullary expression of TNF-{alpha} at day 9.

Conclusions. Neonatal ACE inhibition perturbs medullary tubulogenesis, as indicated by tubular dilatation and a lack of E-cadherin expression in these tubules. Macrophage/monocyte-mediated immune response is a secondary event, coincidentally associated with the up-regulation of TNF-{alpha}.

Keywords: angiotensin-converting enzyme inhibition; E-cadherin; inflammation; renin–angiotensin system; renal development; tubulogenesis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Stubbe, K. Madsen, F. T. Nielsen, R. K. Bonde, O. Skott, and B. L. Jensen
Postnatal adrenalectomy impairs urinary concentrating ability by increased COX-2 and leads to renal medullary injury
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F780 - F789.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Loria, V. Reverte, F. Salazar, F. Saez, M. T. Llinas, and F. J. Salazar
Sex and age differences of renal function in rats with reduced ANG II activity during the nephrogenic period
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F506 - F510.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Saez, M. T. Castells, A. Zuasti, F. Salazar, V. Reverte, A. Loria, and F. J. Salazar
Sex Differences in the Renal Changes Elicited by Angiotensin II Blockade During the Nephrogenic Period
Hypertension, June 1, 2007; 49(6): 1429 - 1435.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Lasaitiene, Y. Chen, V. Mildaziene, Z. Nauciene, B. Sundelin, B. R. Johansson, M. Yano, and P. Friberg
Tubular mitochondrial alterations in neonatal rats subjected to RAS inhibition
Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1260 - F1269.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Guron, J. Molne, S. Swerkersson, P. Friberg, and S. Hansson
A 14-year-old girl with renal abnormalities after brief intrauterine exposure to enalapril during late gestation
Nephrol. Dial. Transplant., February 1, 2006; 21(2): 522 - 525.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Lasaitiene, P. Friberg, B. Sundelin, and Y. Chen
Neonatal RAS inhibition changes the phenotype of the developing thick ascending limb of Henle
Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1144 - F1153.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Y. Chen, D. Lasaitiene, B. G. Gabrielsson, L. M.S. Carlsson, H. Billig, B. Carlsson, N. Marcussen, X.-F. Sun, and P. Friberg
Neonatal Losartan Treatment Suppresses Renal Expression of Molecules Involved in Cell-Cell and Cell-Matrix Interactions
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1232 - 1243.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.